WO2004100954A1 - Treatment of psychotic and depressive ...,https://www.google.com/patents/WO2004100954A1
WO1994003455A1 - Pyridoindolobenzodiazepines and derivatives ...,https://www.google.com/patents/WO1994003455A1
US6362173B1 - Methods for treating psychosis associated with ...,https://google.com/patents/US6362173
WO2003013507A1 - Procede permettant de prevenir ou d'attenuer ...,https://www.google.com/patents/WO2003013507A1?cl=fr
EP2120985B1 - FN-38 peptides for use in the treatment of psychotic ...,https://www.google.com/patents/EP2120985B1?cl=zh:
EP2790021A1 - Bimarkers for schizophrenia or other psychotic ...,https://www.google.com/patents/EP2790021A1?cl=nl
WO2005094801A1 - Use of an nk3 antagonist for the treatment of ...,https://www.google.com/patents/WO2005094801A1
WO2007137590A1 - Sertindole for the preventive treatment of ...,https://www.google.com/patents/WO2007137590A1?cl=es
EP2121606A1 - Glyt1 transporter inhibitors and uses thereof in ...,https://www.google.com/patents/EP2121606A1?cl=en
EP2656080A2 - Biomarkers for diagnosing schizophrenia - Google ...,https://www.google.com/patents/EP2656080A2?cl=un
